Fact check: Experts debunk claim that Covid boosters lead to positive HIV test
PTI, Feb 18, 2022, 1:47 PM IST
HIV test
New Delhi: There is no scientific evidence to back a widely shared claim on social media that Covid boosters can lead to HIV, a supposition attributed to French virologist Luc Montagnier, say experts.
Montagnier, a joint recipient of the 2008 Nobel Prize in Medicine for his discovery of the human immunodeficiency virus (HIV) that can lead to AIDS, died earlier this month. Since then, several Twitter users have shared a quote attributed to him which reads, ”For those of you that have taken the third dose, go and take a test for AIDS. The results may surprise you. Then sue your government.” There is no evidence he made this claim or that Covid boosters make a person susceptible to HIV infection, several experts told PTI.
“I don’t see why would a booster lead to a positive HIV test. We should not be carried away by misinformation and information that are not evidence-based,” said virologist Upasana Ray, senior scientist at Kolkata’s CSIR-Indian Institute of Chemical Biology.
Immunologist Vineeta Bal agreed, saying Covid vaccines do not in any way promote susceptibility to HIV infection. Bal added that there was nothing to indicate that Montaignier made the claim. “There is no evidence that vaccines cause immunosuppression thereby leading to activation of dormant HIV infection either. There can be isolated individuals who test HIV positive but that is likely to be by chance rather than design,” Bal, from Pune’s Indian Institute of Science Education and Research, told PTI.
According to virologist Naga Suresh Veerapu, no scientific evidence to date suggests a link between increased chances of HIV infection after Covid vaccination.
“On a related note, Covid vaccination neither can cause infection with SARS CoV-2 nor with the virus used as the vector for vaccine preparation,” Veerapu, associate professor at Shiv Nadar University, Delhi-NCR, told PTI.
Viral vector vaccines use a modified version of a virus that is different from the virus being targeted to deliver instructions to our cells to tackle the pathogen.
Last year, a Covid vaccine developed by Australia’s University of Queensland and biotech firm CSL was found to interfere with HIV tests, but routine follow-up tests confirmed there was no HIV virus present.
Bal said the vaccine, which was discontinued after the phase 1 clinical trial, used a component of HIV called gp41 as a part of the COVID-19 vaccine.
“Naturally the recipients would develop antibodies to gp41. This was a point which was anticipated and the clinical trial volunteers were briefed about it so that alarm bells do not ring,” she said.
Ray noted that the shelved Australian vaccine should not fuel false claims about authorized COVID-19 vaccines in use around the world.
“Each vaccine candidate is designed differently and if for one a cross-reactivity is found, that doesn’t prove that COVID vaccine triggers HIV,” she explained.
Veerapu said government agencies can run a small clinical trial screening for blood HIV antigen or antibodies prior and after Covid vaccination to promote confidence about the safety of the vaccines.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Plant-based meat alternatives linked to increased risk of depression in vegetarians, study finds
Lung transplant at right time only cure for idiopathic pulmonary fibrosis that killed Ustad Zakir Hussain
ICMR sets up India’s first diabetes biobank in Chennai
AI Meets Health: The Rise of Smart Fitness Solutions
New study links paracetamol to side effects in digestive tract, heart, kidneys among older adults
MUST WATCH
Latest Additions
Assembly clears Mysuru Development Authority Bill
Blocked 18 OTT platforms for publishing obscene, vulgar content: Govt
Boy critically injured after tree branch falls on him in Bengaluru
Congress claims party worker ‘died due to tear gas smoke’ during protest in Assam
Four dead in road accident in Kolar
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.